Clinical Trial Update: Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating icovamenib in adults with type 2 diabetes mellitus who are not reaching glycemic targets on GLP-1-based therapy is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Icovamenib (icovamenib)

Snippet

Sponsor: Biomea Fusion Inc. | Conditions: Type 2 Diabetes | Phase 2 | Status: RECRUITING